Apotex is transforming osteoporosis care across Canada with Health Canada’s green light for DENOZAâ„¢, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
Browsing: drug launch
Bial has proudly launched KYNMOBI® (Apomorphine Hydrochloride) in the United Kingdom, offering a groundbreaking new treatment for patients with Parkinson’s disease experiencing OFF episodes. This thrilling introduction marks a significant milestone in broadening Bial’s innovative portfolio
Eli Lilly is set to introduce its weight-loss drug in emerging markets this year, aiming to address rising obesity rates. The launch follows successful outcomes in developed regions, positioning Lilly to expand its global footprint in the competitive weight management sector.